Fast Five Quiz: HER2+ Breast Cancer

Pavani Chalasani, MD, MPH


September 14, 2020

Breast cancer is the most common cancer in women. According to the International Agency for Research on Cancer, more than 2 million new cases of breast cancer were diagnosed in 2018. Human epidermal growth factor receptor 2–positive (HER2+) breast cancer accounts for up to 15% to 20% of all breast cancers. Patients with HER2+ breast cancer have a worse prognosis than patients with some other types of breast cancer, but new targeted treatments have significantly improved survival rates.

How much do you know about HER2+ breast cancer? Test your knowledge with this quick quiz.


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.
Post as: